Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Almotriptan increases sustained pain-free outcomes in acute migraine: Results from three controlled clinical trials
David W. Dodick
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Almotriptan increases sustained pain-free outcomes in acute migraine: Results from three controlled clinical trials'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
almotriptan
100%
Pain-Free
67%
Controlled Clinical Trials
62%
Migraine Disorders
57%
Sumatriptan
26%
Placebos
26%
Pain
14%
Recurrence
7%
Therapeutics
1%